Prospects for the Development of a Vaccine Against Helicobacter pylori
Over 50% of the world population is chronically infected by the gastric pathogen, Helicobacter pylori, which is responsible for most peptic ulcer disease and is closely associated with adenocarcinoma of the stomach. Current therapies for peptic ulcer disease include antibiotic eradication of H. pylori infection. While effective, the high cost, difficulty of patient compliance with the treatment regimens, and risks of selection for resistant strains make these therapies impractical on a large scale. Studies of the pathogenesis of H. pylori have led to the identification of bacterial antigens as candidates for inclusion in novel vaccines against this disease. Both prophylactic and therapeutic vaccination have been demonstrated in animal models of Helicobacter infection. Preclinical evaluations of several antigens are at present under way and trials of vaccination in humans are planned.
Unable to display preview. Download preview PDF.
- 10.Josenhans C, Labigne A, Suerbaum S. Comparative ultrastructural and functional studies of Helicobacter pylori and Helicobacter mustelae flagellin mutants: both flagellin subunits, FlaA and FlaB, are necessary for full motility in Helicobacter species. J Bacteriol 1995; 177: 3010–20CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Xiang ZY, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94–8PubMedPubMedCentralGoogle Scholar
- 26.Corthesy-Theulaz I, Haas R, Davin C, et al. Helicobacter pylori urease protection against Helicobacter felis infection in mice. Acta Gastroenterol Belgica 1993; 56: 64Google Scholar
- 29.Ghiara P, Marchetti M, Di Tommaso A, et al. Infection by Helicobacter pylori in a mouse model that mimics human disease: protection by oral immunization [abstract]. Gut 1995; 37 Suppl. 1:A51Google Scholar
- 31.Corthésy-Theulaz I, Vaney AC, Haas R, et al. H. pylori urease B subunit as a therapeutical vaccine against H. felis infection [abstract]. Gastroenterology 1994; 106 (4 Pt 2): A668Google Scholar
- 35.Nedrud J, Blanchard T, Czinn S, et al. Recombinant cholera toxin B subunit is not an adjuvant for oral immunization against Helicobacter felis in mice [abstract]. J Cell Biochem 1995; Suppl. 19A: 261Google Scholar